Literature DB >> 12227503

HEC-1 cells.

Hiroyuki Kurarmoto1, Mieko Hamano, Manami Imai.   

Abstract

HEC-1 cell line was the first in vitro cell line of a human endometrial adenocarcinoma which enabled us to perform research work on the endometrium and endometrial carcinoma at a simplified cellular system, contributing cell and molecular biological studies on endometrial carcinoma. Once a cell line is established, it provides a stable experimental system that facilitates and progresses in the study of the tissues and/or neoplasias from which they are derived. In this article we report how HEC-1 cells have been established and cleared the proposed requirements to characterize the established cell line. Also to show the usefulness of the cell line for research work, once it was established, we illustrate these concepts by recalling results obtained with HEC-1 cells and reviewing the literature on what has been achieved by using these cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12227503     DOI: 10.1111/j.1749-0774.2002.tb00103.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  90 in total

1.  [Scanning electron microscopic studies on the cell surface and cell synchronized culture of human endometrial adenocarcinoma (HEC-1) cells].

Authors:  K Harada; T Miura; S Saitoh; N Yoshizumi; T Izutsu; T Kagabu; I Nishiya
Journal:  Nihon Sanka Fujinka Gakkai Zasshi       Date:  1987-04

2.  Anti-Müllerian hormone is not cytotoxic to human endometrial cancer in tissue culture.

Authors:  Z Rosenwaks; H C Liu; J Y Picard; N Josso
Journal:  J Clin Endocrinol Metab       Date:  1984-07       Impact factor: 5.958

3.  Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.

Authors:  Y Katsuki; Y Shibutani; D Aoki; S Nozawa
Journal:  Cancer       Date:  1997-01-01       Impact factor: 6.860

4.  Recombinant Escherichia coli clones expressing Chlamydia trachomatis gene products attach to human endometrial epithelial cells.

Authors:  D H Schmiel; S T Knight; J E Raulston; J Choong; C H Davis; P B Wyrick
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  Proliferation and responsiveness to estrogen of human endometrial cancer cells under serum-free culture conditions.

Authors:  C F Holinka; Y Anzai; H Hata; N Kimmel; H Kuramoto; E Gurpide
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

6.  Estradiol metabolism in Ishikawa endometrial cancer cells.

Authors:  H Hata; C F Holinka; S L Pahuja; R B Hochberg; H Kuramoto; E Gurpide
Journal:  J Steroid Biochem       Date:  1987-06       Impact factor: 4.292

7.  Cytogenetics of an endometrial adenocarcinoma cell line and its implications.

Authors:  J S Noumoff; D Simon; S Heyner; M Farber; S W Haydock; M L Pritchard
Journal:  Gynecol Oncol       Date:  1988-09       Impact factor: 5.482

8.  [Growth regulation of sex steroid hormone in endometrial carcinoma transplanted into nude mice].

Authors:  Y Kato; T Morisawa; H Kuramoto
Journal:  Hum Cell       Date:  1991-06       Impact factor: 4.174

9.  Identification of a distal regulatory sequence of the human IGFBP-1 gene promoter and regulation by the progesterone receptor in a human endometrial adenocarcinoma cell line.

Authors:  J G Gao; J Mazella; D R Powell; L Tseng
Journal:  DNA Cell Biol       Date:  1994-08       Impact factor: 3.311

10.  Effects of estradiol on deoxyribonucleic acid polymerase alpha activity in the Ishikawa human endometrial adenocarcinoma cell line.

Authors:  A Gravanis; E Gurpide
Journal:  J Clin Endocrinol Metab       Date:  1986-08       Impact factor: 5.958

View more
  9 in total

1.  Transcriptomic analysis of the interaction of choriocarcinoma spheroids with receptive vs. non-receptive endometrial epithelium cell lines: an in vitro model for human implantation.

Authors:  Paula Vergaro; Gustavo Tiscornia; Amelia Rodríguez; Josep Santaló; Rita Vassena
Journal:  J Assist Reprod Genet       Date:  2019-04-10       Impact factor: 3.412

2.  DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination.

Authors:  Christopher Korch; Monique A Spillman; Twila A Jackson; Britta M Jacobsen; Susan K Murphy; Bruce A Lessey; V Craig Jordan; Andrew P Bradford
Journal:  Gynecol Oncol       Date:  2012-06-16       Impact factor: 5.482

3.  Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines.

Authors:  Andrea Schröpfer; Ulrike Kammerer; Michaela Kapp; Johannes Dietl; Sonja Feix; Jelena Anacker
Journal:  BMC Cancer       Date:  2010-10-13       Impact factor: 4.430

4.  Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.

Authors:  Meghan L Rudd; Hassan Mohamed; Jessica C Price; Andrea J O'Hara; Matthieu Le Gallo; Mary Ellen Urick; Pedro Cruz; Suiyuan Zhang; Nancy F Hansen; Andrew K Godwin; Dennis C Sgroi; Tyra G Wolfsberg; James C Mullikin; Maria J Merino; Daphne W Bell
Journal:  BMC Cancer       Date:  2014-11-26       Impact factor: 4.430

5.  PKN1 modulates TGFβ and EGF signaling in HEC-1-A endometrial cancer cell line.

Authors:  Sanaz Attarha; Ravi Kanth Rao Saini; Sonia Andersson; Miriam Mints; Serhiy Souchelnytskyi
Journal:  Onco Targets Ther       Date:  2014-08-04       Impact factor: 4.147

6.  MiR-369-3p participates in endometrioid adenocarcinoma via the regulation of autophagy.

Authors:  Ping Liu; Chengbin Ma; Qiongwei Wu; Wenying Zhang; Cao Wang; Li Yuan; Xiaowei Xi
Journal:  Cancer Cell Int       Date:  2019-07-11       Impact factor: 5.722

7.  Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cells.

Authors:  Chunxiao Zhou; Tara A Steplowski; Hallum K Dickens; Kimberly M Malloy; Paola A Gehrig; John F Boggess; Victoria L Bae-Jump
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

8.  Extracts from Acacia catechu suppress HIV-1 replication by inhibiting the activities of the viral protease and Tat.

Authors:  Manoj Modi; Charlene S Dezzutti; Shweta Kulshreshtha; Ajay Kumar Singh Rawat; Sharad Kumar Srivastava; Swadesh Malhotra; Anjali Verma; Udaykumar Ranga; Satish Kumar Gupta
Journal:  Virol J       Date:  2013-10-18       Impact factor: 4.099

9.  MicroRNA-23a regulates epithelial-to-mesenchymal transition in endometrial endometrioid adenocarcinoma by targeting SMAD3.

Authors:  Ping Liu; Chao Wang; Chengbin Ma; Qiongwei Wu; Wenying Zhang; Guoying Lao
Journal:  Cancer Cell Int       Date:  2016-09-05       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.